MetaVia Inc.
MTVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001638287
No open-market purchases or sales by MetaVia Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $414.0K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in MetaVia Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q1 2025
- Shares held
- 266.2K
- −446.6K (−62.7%) vs. Q1 2025
- Total value
- $171.2K
- −$926.3K (−84.4%) vs. Q1 2025
- New holders
- 3
- 5 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $414.0K |
| Q1 2026 | 12 | $80.4K |
| Q4 2025 | 11 | $306.0K |
| Q3 2025 | 16 | $425.2K |
| Q2 2025 | 15 | $171.2K |
| Q1 2025 | 14 | $1.10M |
| Q4 2024 | 15 | $1.84M |
| Q3 2024 | 13 | $3.47M |
| Q2 2024 | 12 | $4.32M |
| Q1 2024 | 13 | $398.3K |
| Q4 2023 | 8 | $245.4K |
| Q3 2023 | 14 | $193.6K |
| Q2 2023 | 8 | $38.8K |
| Q1 2023 | 9 | $73.8K |
| Q4 2022 | 17 | $1.00M |
| Q3 2022 | 9 | $219.5K |
| Q2 2022 | 21 | $582.0K |
| Q1 2022 | 20 | $1.20M |
| Q4 2021 | 20 | $2.06M |
| Q3 2021 | 18 | $2.79M |
| Q2 2021 | 27 | $2.86M |
| Q1 2021 | 31 | $6.56M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding MetaVia Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 63,582 | $40.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 58,584 | $37.7K | 0.00% | +53,281+1,004.7% | Added |
| SG Americas Securities, LLC | 41,880 | $27.0K | 0.00% | +880+2.1% | Added |
| Geode Capital Management, LLC | 35,872 | $23.1K | 0.00% | −4,513−11.2% | Reduced |
| XTX Topco Ltd | 16,628 | $10.7K | 0.00% | +16,628 | New |
| State Street Corp | 15,633 | $10.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,508 | $8.69K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 10,495 | $6.75K | 0.01% | +10,495 | New |
| BlackRock, Inc. | 5,274 | $3.39K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,088 | $2.63K | 0.00% | +1,662+68.5% | Added |
| Mount Yale Investment Advisors, LLC | 276 | $178 | 0.00% | +276 | New |
| SBI Securities Co., Ltd. | 262 | $169 | 0.00% | +260+13,000.0% | Added |
| Bank of America Corp | 67 | $43 | 0.00% | +36+116.1% | Added |
| Brown Brothers Harriman & Co | 27 | $17 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −525,605−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −6−100.0% | Sold out |